Skip to main content
. 2021 Nov 23;29(4):2231–2239. doi: 10.1245/s10434-021-11088-6

Fig. 1.

Fig. 1

Percent of HR+/HER2- patients undergoing NET by AJCC 8th edition clinical prognotic stage